Kevin P. Kerns

Array ( [id] => 7561268 [patent_doc_number] => 20110275101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS' [patent_app_type] => utility [patent_app_number] => 13/102917 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3477 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275101.pdf [firstpage_image] =>[orig_patent_app_number] => 13102917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435146 [patent_doc_number] => 08282914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Method for treating atherosclerosis by administering human MCP1 fusions' [patent_app_type] => utility [patent_app_number] => 13/098641 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18240 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499427 [patent_doc_number] => 20110262435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'IL-13 BINDING AGENTS' [patent_app_type] => utility [patent_app_number] => 13/098668 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38113 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262435.pdf [firstpage_image] =>[orig_patent_app_number] => 13098668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034845 [patent_doc_number] => 20130237484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'HUMAN-DERIVED CELL-PERMEABLE PEPTIDE BIOACTIVE PEPTIDE CONJUGATE, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/821790 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11530 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167187 [patent_doc_number] => 20110195906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'OSTEOGENIC SYNTHETIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND MEDIUM CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/093053 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 4861 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195906.pdf [firstpage_image] =>[orig_patent_app_number] => 13093053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164848 [patent_doc_number] => 20110195062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Mammalian Cytokines; Related Reagents and Methods' [patent_app_type] => utility [patent_app_number] => 13/089145 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195062.pdf [firstpage_image] =>[orig_patent_app_number] => 13089145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657483 [patent_doc_number] => 20110306752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'MUTANT INTERLEUKIN-2 (IL-2) POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/088045 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18221 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306752.pdf [firstpage_image] =>[orig_patent_app_number] => 13088045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650830 [patent_doc_number] => 20110300099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 13/086698 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14884 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300099.pdf [firstpage_image] =>[orig_patent_app_number] => 13086698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10897851 [patent_doc_number] => 08921064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Method for purifying urate oxidase tetramers and octamers' [patent_app_type] => utility [patent_app_number] => 13/085793 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7184 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853133 [patent_doc_number] => 20130142808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'ANTIBODY RECOGNIZING HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) AND USE OF ANTI-LIF ANTIBODIES IN THE TREATMENT OF DISEASES ASSOCIATED WITH UNWANTED CELL PROLIFERATION' [patent_app_type] => utility [patent_app_number] => 13/261464 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14084 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755211 [patent_doc_number] => 20130089516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'PROTEASE ACTIVATED CYTOKINES' [patent_app_type] => utility [patent_app_number] => 13/639006 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14482 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6165821 [patent_doc_number] => 20110195500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'METHODS AND COMPOSITIONS FOR MITIGATING EOSINOPHILIC ESOPHAGITIS BY MODULATING LEVELS AND ACTIVITY OF EOTAXIN-3' [patent_app_type] => utility [patent_app_number] => 13/051873 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3527 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195500.pdf [firstpage_image] =>[orig_patent_app_number] => 13051873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696177 [patent_doc_number] => 20110230413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO GLATIRAMER ACETATE THERAPY IN MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/049720 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16791 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230413.pdf [firstpage_image] =>[orig_patent_app_number] => 13049720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823530 [patent_doc_number] => 08933014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'HJURP peptides and vaccines including the same' [patent_app_type] => utility [patent_app_number] => 13/583195 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 31246 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173451 [patent_doc_number] => 20120108452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Semi-Invasive Method for Characterizing Lung Injury' [patent_app_type] => utility [patent_app_number] => 13/044496 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 15102 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108452.pdf [firstpage_image] =>[orig_patent_app_number] => 13044496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8587128 [patent_doc_number] => 20130005949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/582989 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17399 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046759 [patent_doc_number] => 20110206698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ANTAGONIST ANTI-IL-7 RECEPTOR ANTIBODIES AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/033491 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 35734 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206698.pdf [firstpage_image] =>[orig_patent_app_number] => 13033491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937263 [patent_doc_number] => 20110212853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'NOVEL DIAGNOSTIC METHOD' [patent_app_type] => utility [patent_app_number] => 13/030258 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 22804 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212853.pdf [firstpage_image] =>[orig_patent_app_number] => 13030258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212297 [patent_doc_number] => 20110135597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Uses of Mammalian Cytokine; Related Reagents' [patent_app_type] => utility [patent_app_number] => 13/026601 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13609 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135597.pdf [firstpage_image] =>[orig_patent_app_number] => 13026601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660016 [patent_doc_number] => 20130040845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONS' [patent_app_type] => utility [patent_app_number] => 13/577935 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24169 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577935 [rel_patent_id] =>[rel_patent_doc_number] =>)